HBI
56
8
NEE
41
7
EXR
39
2
UNM
66
7
MRK
27
-5
PRGO
25
-6
PPL
49
4
MHK
42
5
ADT
33
6
TDC
60
3
LOW
46
4
AES
37
2
JCI
45
3
DVA
71
5
PVH
39
2
CI
38
3
STT
56
2
ED
45
2
CVX
37
2
MAS
52
9
HBI
56
8
NEE
41
7
EXR
39
2
UNM
66
7
MRK
27
-5
PRGO
25
-6
PPL
49
4
MHK
42
5
ADT
33
6
TDC
60
3
LOW
46
4
AES
37
2
JCI
45
3
DVA
71
5
PVH
39
2
CI
38
3
STT
56
2
ED
45
2
CVX
37
2
MAS
52
9
Financhill
Back

Genpact Vs. SpringWorks Therapeutics Industry Stock Comparison

Buy
62

G
Genpact

Last Price:
$44.27
Seasonality Move:
2.42%
Sell
9

SWTX
SpringWorks Therapeutics

Last Price:
$33.91
Seasonality Move:
-2.03%
Buy
62
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $44.20. The Score for G is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
9
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $32.50. The Score for SWTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $44.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing selling pressure, which indicates risk of future bearish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 56.09 Buy
Chaikin Money Flow: -981301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.61 - 44.45) Buy
Bollinger Bands (100): (38.43 - 44.33) Buy

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -2546118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.59 - 40.53) Sell
Bollinger Bands (100): (31.91 - 40.11) Sell

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.55 Buy
20-day SMA: 43.19 Buy
50-day SMA: 43.89 Buy
200-day SMA: 37.11 Buy
8-day EMA: 43.64 Buy
20-day EMA: 43.56 Buy
50-day EMA: 43.05 Buy
200-day EMA: 39.16 Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.42 Sell
20-day SMA: 37.4 Sell
50-day SMA: 37.33 Sell
200-day SMA: 38.27 Sell
8-day EMA: 37.61 Sell
20-day EMA: 37.86 Sell
50-day EMA: 37.24 Sell
200-day EMA: 37 Sell

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.32 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):